Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Andrew DeRyke

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
BMC Microbiology|June 13, 2023
Relebactam restores susceptibility of resistant Pseudomonas aeruginosa and Enterobacterales and enhances imipenem activity against chromosomal AmpC-producing species: analysis of global SMART 2018-2020David W Hilbert, C Andrew DeRyke, Mary Motyl, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 22, 2012
Performance of a vancomycin dosage regimen developed for obese patientsDavid C Reynolds, Laura H Waite, Donald P Alexander, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2006
Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus speciesC Andrew DeRyke, Christina Sutherland, Bo Zhang, et al.
Springerplus|January 15, 2014
The impact of initial antibiotic therapy (linezolid, vancomycin, daptomycin) on hospital length of stay for complicated skin and soft tissue infectionsEwa Szczypinska, Alexander Velazquez, Diana Salazar, et al.
The Annals of Pharmacotherapy|May 3, 2007
Treatment of Serratia marcescens meningitis with prolonged infusion of meropenemAnthony M Nicasio, Richard Quintiliani, C Andrew DeRyke, et al.
Open Forum Infectious Diseases|October 27, 2018
Carbapenem-Nonsusceptible Gram-Negative Pathogens in ICU and Non-ICU Settings in US Hospitals in 2017: A Multicenter StudyEilish McCann, Arjun Srinivasan, C Andrew DeRyke, et al.
Drugs in R&D|November 27, 2014
Stability and recovery of DIFICID(®) (Fidaxomicin) 200-mg crushed tablet preparations from three delivery vehicles, and administration of an aqueous dispersion via nasogastric tubeAnna Tousseeva, J Derek Jackson, Mark Redell, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2019
A Combination Antibiogram Evaluation for <i>Pseudomonas aeruginosa</i> in Respiratory and Blood Sources from Intensive Care Unit (ICU) and Non-ICU Settings in U.S. HospitalsLaura Puzniak, Daryl D DePestel, Arjun Srinivasan, et al.
Therapeutic Advances in Infectious Disease|May 17, 2021
Antimicrobial stewardship and antibiograms: importance of moving beyond traditional antibiogramsKenneth P Klinker, Levita K Hidayat, C Andrew DeRyke, et al.
Jac-Antimicrobial Resistance|September 18, 2024
Susceptibility of Gram-negative pathogens collected in Israel to ceftolozane/tazobactam, imipenem/relebactam and comparators: SMART 2018-22Mark G Wise, C Andrew DeRyke, Irina Alekseeva, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
BMC Microbiology|June 13, 2023
Relebactam restores susceptibility of resistant Pseudomonas aeruginosa and Enterobacterales and enhances imipenem activity against chromosomal AmpC-producing species: analysis of global SMART 2018-2020David W Hilbert, C Andrew DeRyke, Mary Motyl, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 22, 2012
Performance of a vancomycin dosage regimen developed for obese patientsDavid C Reynolds, Laura H Waite, Donald P Alexander, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2006
Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus speciesC Andrew DeRyke, Christina Sutherland, Bo Zhang, et al.
Springerplus|January 15, 2014
The impact of initial antibiotic therapy (linezolid, vancomycin, daptomycin) on hospital length of stay for complicated skin and soft tissue infectionsEwa Szczypinska, Alexander Velazquez, Diana Salazar, et al.
The Annals of Pharmacotherapy|May 3, 2007
Treatment of Serratia marcescens meningitis with prolonged infusion of meropenemAnthony M Nicasio, Richard Quintiliani, C Andrew DeRyke, et al.
Open Forum Infectious Diseases|October 27, 2018
Carbapenem-Nonsusceptible Gram-Negative Pathogens in ICU and Non-ICU Settings in US Hospitals in 2017: A Multicenter StudyEilish McCann, Arjun Srinivasan, C Andrew DeRyke, et al.
Drugs in R&D|November 27, 2014
Stability and recovery of DIFICID(®) (Fidaxomicin) 200-mg crushed tablet preparations from three delivery vehicles, and administration of an aqueous dispersion via nasogastric tubeAnna Tousseeva, J Derek Jackson, Mark Redell, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2019
A Combination Antibiogram Evaluation for <i>Pseudomonas aeruginosa</i> in Respiratory and Blood Sources from Intensive Care Unit (ICU) and Non-ICU Settings in U.S. HospitalsLaura Puzniak, Daryl D DePestel, Arjun Srinivasan, et al.
Therapeutic Advances in Infectious Disease|May 17, 2021
Antimicrobial stewardship and antibiograms: importance of moving beyond traditional antibiogramsKenneth P Klinker, Levita K Hidayat, C Andrew DeRyke, et al.
Jac-Antimicrobial Resistance|September 18, 2024
Susceptibility of Gram-negative pathogens collected in Israel to ceftolozane/tazobactam, imipenem/relebactam and comparators: SMART 2018-22Mark G Wise, C Andrew DeRyke, Irina Alekseeva, et al.
Pageof 5